Target intelligence / Profile preview

ZNF571 antisense RNA 1 (ZNF571-AS1)

Target
ZNF571-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

ZNF571 antisense RNA 1 (ZNF571-AS1) is a **long non-coding RNA (lncRNA)** that is transcribed in the antisense orientation relative to the ZNF571 gene on chromosome 19[13]. As an **antisense lncRNA**, ZNF571-AS1 does not encode a protein but likely regulates the expression of the neighboring zinc finger protein 571 (ZNF571) gene and potentially other targets through mechanisms such as modulation of mRNA stability, chromatin modification, and/or acting as a competing endogenous RNA[1][2][5][7]. Subcellular localization predictions suggest it is primarily found in the nucleus, consistent with roles in gene expression regulation and epigenetic modification[5]. Currently, ZNF571-AS1 is not a well-established therapeutic target (such as a receptor, enzyme, or transporter), nor are there any drugs known to directly interact with this molecule. However, its differential expression in cardiac diseases, particularly in patients with dilated cardiomyopathy, points to a possible biomarker role for disease status or response to hemodynamic interventions such as LVAD support[5]. Further functional research may clarify additional roles in human health and disease, but as of now, no direct disease associations (beyond biomarker status) or therapeutic implications have been conclusively demonstrated for ZNF571-AS1.

Other names
CTD-3064H18.6ZNF571-AS1
02

Biological functions

Regulation of gene expressionModulation of mRNA stabilityPotential epigenetic regulationCompeting endogenous RNA (ceRNA) function
03

Disease associations

Potential biomarker in dilated cardiomyopathy (DCM); implicated in cardiac disease states through altered expression
04

Biomarkers

Potential biomarker for disease status in dilated cardiomyopathy (in association with left ventricular assist device [LVAD] support)

Beyond the preview

Go deeper on ZNF571 antisense RNA 1 (ZNF571-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF571 antisense RNA 1 (ZNF571-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call